DDI (Drug-Drug Interaction): Clinical Trials

5 trials for DDI (Drug-Drug Interaction), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Recruiting 3, Completed 2

Follow DDI (Drug-Drug Interaction): new trials by email Literature Review of DDI (Drug-Drug Interaction) trials Research Report on DDI (Drug-Drug Interaction)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug-Drug Interaction Study of Vorolanib Tablets in Healthy Participants
vorolanib and rifampicin, vorolanib and itraconazole - DDI (Drug-Drug Interaction)
Phase 1RecruitingBetta Pharmaceuticals Co., Ltd.362026-09-012026-09-09
Drug-Drug Interaction Study of Befotertinib Capsules in Healthy Participants.
Befotertinib and rifampicin, Befotertinib and itraconazole - DDI (Drug-Drug Interaction)
Phase 1RecruitingBetta Pharmaceuticals Co., Ltd.362026-09-012026-09-09
Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide
Entecavir, Tenofovir Disoproxil Fumarate(TDF), Tenofovir alafenamide(TAF) - Chronic Hepatitis B Liver Fibrosis, DDI (Drug-Drug Interaction)
Phase 1CompletedBeijing Continent Pharmaceutical Co, Ltd.642026-03-152026-08-13
Drug-Drug Interaction Study of ABP-671 in Gout Patients
ABP-671 plus allopurinol - Gout Chronic, Gout
Phase 1RecruitingAtom Therapeutics Co., Ltd202026-01-232026-04-14
A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects
ASP1707, itraconazole - Pharmacokinetics, DDI (Drug-Drug Interaction)
Phase 1CompletedAstellas Pharma Europe B.V.142014-04-012014-07-03

Narrower conditions

Gout (1)

Broader conditions

Arthritis (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Crystal Arthropathies (1)  ·  Genetic Diseases, Inborn (1)  ·  Joint Diseases (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Musculoskeletal Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Purine-Pyrimidine Metabolism, Inborn Errors (1)  ·  Rheumatic Diseases (1)

Interventions

Itraconazole (3)  ·  Rifampin (2)  ·  Allopurinol (1)  ·  entecavir (1)  ·  opigolix (1)  ·  vorolanib (1)

Sponsors

Betta Pharmaceuticals Co., Ltd. (2)  ·  Astellas Pharma Europe B.V. (1)  ·  Atom Therapeutics Co., Ltd (1)  ·  Beijing Continent Pharmaceutical Co, Ltd. (1)

Countries

China (3)  ·  Germany (1)  ·  United States (1)